US OptionsDetailed Quotes
TGTX250502P46500
- 1.25
- 0.000.00%
15min DelayClose May 2 16:00 ET
0.00High0.00Low
1.25Open1.25Pre Close0 Volume5 Open Interest46.50Strike Price0.00Turnover1806.43%IV-4.17%PremiumMay 2, 2025Expiry Date3.06Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8972Delta0.0818Gamma14.36Leverage Ratio-68.1493Theta0.0000Rho-12.88Eff Leverage0.0002Vega
TG Therapeutics Stock Discussion
Game-Changing MS Treatment? BRIUMVI Single-Dose Trial Reveals Breakthrough Potential
Game-Changing MS Treatment: BRIUMVI Reveals Exceptional Real-World Safety Profile
Medical Journals Reveal Breakthrough: BRIUMVI Succeeds Where Other MS Treatments Fall Short
How TG Therapeutics Transformed from Clinical-Stage to Profitable Biotech with 250% Revenue Growth
Can BRIUMVI Succeed Where Other MS Treatments Failed? New Clinical Data Reveals Promising Results
Larger Image: tradingview.com...
$TG Therapeutics (TGTX.US)$
No comment yet